A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia

Gut

Volumn 46, Issue 5, 2000, Pages 597-600

  Annese, V ^a   Andriulli, A ^a   Bassotti, G ^b   Coccia, G ^c   Dinelli, M ^d   D'Onofrio, V ^e   Gatto, G ^f   Leandro, G ^a   Repici, A ^g   Testoni, P A ^h  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^f VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h Policlinico S Marco   (Italy)

Author keywords

Achalasia; Botulinum toxin; Dose ranging study; Oesophagus

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; FEMALE; FOOD REGURGITATION; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL ACHALASIA; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MANOMETRY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 0034021050     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.597     Document Type: Article

References (20)

1. 1 Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994;121:590-1.
2. 2 Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774-8.
3. 3 Annese V, Basciani M, Lombardi G, et al. Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc 1996;44:461-5.
4. 4 Cuilliére C, Ducrotté P, Zerbib F, et al. Achalasia : outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997;41:87-92.
5. 5 Gordon JM, Eaker EY. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997;92:1812-17.
6. 6 Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996;110:1410-15.
7. 7 Annese V, Basciani M, Perri F, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996;111:1418-24.
8. 8 Annese V, Basciani M, Borrelli O, Leandro G, Simone P, Andriulli A. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle Nerve 1998;21:1540-2.
9. 9 Bassotti G, Battaglia E, Debernardi V, et al. Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 1997;40:2252-8.
10. 10 Goldenberg SP, Burell M, Fette GG, Vos C, Traube M. Classic and vigorous achalasia: a comparison of manometric, radiographic and clinical findings. Gastroenterology 1991;101:743-8.
11. 11 Jancovic J, Brin MF. Therapeutic use of botulinum toxin. N Engl J Med 1991;324:1186-94
12. 12 Cohen S, Parkman HP. Treatment of achalasia - from whalebone to botulinum toxin. N Engl J Med 1995;332: 815-16.
13. 13 Pasricha PJ, Ravich WJ, Kalloo AN. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 1993;105:1045-9.
14. 14 Castell DO, Katzka DA. Botulinum toxin for achalasia: to be or not to be? Gastroenterology 1996;110:1650-2.
15. 15 Vaezi MF, Richter JE. Current therapy for achalasia. Comparison and efficacy. J Clin Gastroenterol 1998;27:21-35.
16. 16 Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilation in the treatment of achalasia: a randomised study. Gut 1999;44:231-9.
17. 17 Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91:1724-30.
18. 18 Jancovic J. Botulinum toxin in movement disorders. Curr Opin Neurol 1994;7:358-66.
19. 19 Brin ME. Botulinum toxin: chemistry, pharmacology, toxicity and immunology. Muscle Nerve 1997; (suppl 7):S146-68.
20. 20 Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994;9:213-17.